Table 1 The correlation between miR-770 expression and clinicopathological characteristics in glioma patients
From: MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
Characteristics | All patients | miR-770 expression | P value | |
|---|---|---|---|---|
High (n = 11) | Low (n = 52) | |||
Gender | 0.697 | |||
 Male | 39 | 7 | 32 | |
 Female | 24 | 4 | 20 | |
Age (years) | 0.735 | |||
 ≥ 50 | 35 | 6 | 29 | |
 < 50 | 28 | 5 | 23 | |
WHO grade | < 0.001 | |||
 I + II | 23 | 8 | 15 | |
 III + IV | 40 | 3 | 37 | |
IDH1 | < 0.001 | |||
 Mutation | 29 (Nod:13; Cod:16) | 2 | 27 | |
 Wild type | 34 (Nod:28; Cod:6) | 9 | 25 | |
1p/19q | 0.053 | |||
 No deletion | 41 | 6 | 35 | |
 Codeletion | 22 | 5 | 17 | |
Tumor size (cm) | 0.163 | |||
 ≥ 5 | 36 | 5 | 31 | |
 < 5 | 27 | 6 | 21 | |
KPS score | < 0.001 | |||
 < 80 | 29 | 8 | 21 | |
 ≥ 80 | 34 | 3 | 31 | |